Want to join the conversation?
Pharmaceutical company $PFE announced top-line results from its OPAL Broaden trial, the first Phase 3 study investigating tofacitinib for treating psoriatic arthritis. OPAL Broaden met its primary efficacy endpoints, showing that both tofacitinib 5 mg BID and 10 mg BID were superior to treatment with placebo at 3 months.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.